美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco S&P 500 Equal Weight Health Care ETF

36.73

-0.2400-0.65%

盤後：36.730.00000.00%19:30 EDT

成交量：4.75萬

成交額：174.59萬

市值：9.03億

市盈率：- -

高：36.83

開：36.79

低：36.69

收：36.97

52周最高：38.19

52周最低：28.26

股本：2,458.00萬

流通股本：2,458.00萬

量比：0.35

換手率：0.19%

股息：0.23

股息率：0.63%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

減重版司美格魯肽在中國獲批脂肪肝適應證，影響多大？

透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理

賽諾醫療：關於參加上海證券交易所科創板2026年半年度醫療器械及醫療設備行業集體業績説明會的公告

市場消息：派拉蒙天空之舞採取措施防範延期產生的成本，華納兄弟探索併購交易即將完成。

美國醫療保險和醫療補助服務中心：禁止11家涉嫌欺詐金額超過34億美元的醫療用品公司未來獲得聯邦醫療保險優勢計劃C部分和D

百事(PEP)拓展冷藏生鮮等新品類應對GLP-1藥物帶來消費行為變化

邁普醫學：可吸收止血流體明膠作為第三類醫療器械進入臨床試驗

中信建投：醫療器械業績持續改善醫療服務收入平穩增長

諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率

諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率

三諾生物：取得醫療器械註冊證及註冊變更文件

安圖生物：公司及子公司獲得四項醫療器械註冊證

麥科田（2041.HK）登陸港交所，平台型醫療器械龍頭起航

山東省寧陽縣市場監管局開展醫療器械專項現場檢查

中国质量新闻网

又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？

高瓴重倉的醫療器械公司，IPO首日開盤跌超30%

海南出台醫療器械委託生產監管新政

格式塔創始人彭雷：三到五年內，腦機接口本質上是嚴肅的醫療器械

美國衞生與公眾服務部醫療保險和醫療補助服務中心：特朗普政府宣佈撥款1.2億美元，用於擴大印第安納州母嬰健康服務，提高初級

浩歐博(688656.SH)子公司獲得13項醫療器械註冊證

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/RSPH/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":36.73,"timestamp":1789761600000,"preClose":36.97,"halted":0,"volume":47475,"hourTrading":{"tag":"盘后","latestPrice":36.73,"preClose":36.73,"latestTime":"19:30 EDT","volume":42,"amount":1545.46,"timestamp":1789774207075,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.00649175006762245,"floatShares":24580000,"shares":24580000,"eps":0,"marketStatus":"休市中","change":-0.24,"latestTime":"09-18 16:00:00 EDT","open":36.79,"high":36.83,"low":36.6901,"amount":1745866.5389999999,"amplitude":0.003784,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":36.97,"sharesOutstanding":23410000,"nav":36.94091,"aum":908253429.86,"dividendRate":0.006341,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.97,"preClose":36.97,"latestTime":"07:54 EDT","volume":2,"amount":73.94,"timestamp":1789732460947,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.73,"preClose":36.73,"latestTime":"19:30 EDT","volume":42,"amount":1545.46,"timestamp":1789774207075,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.3508091332298825,"impliedVol":0.0046,"impliedVolPercentile":0.0199},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":24580000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3508091332298825,"shares":24580000,"dividePrice":0.2329,"high":36.83,"amplitude":0.003784,"preClose":36.97,"low":36.6901,"week52Low":28.26,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":36.73,"eps":0,"divideRate":0.006341,"volume":47475,"delay":0,"ttmEps":0,"open":36.79,"prevYearClose":31.85,"prevWeekClose":36.08,"prevMonthClose":37.4,"prevQuarterClose":33.19,"fiveDayClose":36.08,"twentyDayClose":37.23,"sixtyDayClose":32.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"RSPH","amount":0.05159,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.04585,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666655248","title":"減重版司美格魯肽在中國獲批脂肪肝適應證，影響多大？","url":"https://stock-news.laohu8.com/highlight/detail?id=2666655248","media":"澎湃新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666655248?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 12:00","pubTimestamp":1789012800,"startTime":"0","endTime":"0","summary":"诺和诺德将中国减肥药的竞争正式拉到了脂肪肝领域。9月10日，澎湃新闻记者从诺和诺德获悉，减重版司美格鲁肽注射液（商品名：诺和盈）的代谢相关脂肪性肝炎（MASH）适应证上市申请获得中国国家药品监督管理局（NMPA）批准，适用于治疗代谢相关脂肪性肝炎（MASH）伴中重度肝纤维化（符合F2-F3期纤维化）的非肝硬化成人患者，成为首个且唯一获批用于治疗MASH的GLP-1RA类药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609103870407810.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609103870407810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0244354667.USD","LU2097828714.EUR","BK1161","THNR","LU2097828557.USD","LU0149534421.HKD","LU1969619763.USD","LU1188198961.HKD","LU0326950275.SGD","LU0607220059.USD","LU2242644610.SGD","KURE","LU2097828631.EUR","NVOX","NVOC","LU0455707207.USD","RSPH","BK1583","NVOH","LU0463099449.HKD","LU0502904849.HKD","JDOC","LU2328871848.SGD","LU2097828474.EUR","MEDI","01801","LU1831875114.USD","LU2097828805.USD","HK0000165453.HKD","LU2488822045.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666755282","title":"透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2666755282","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666755282?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 11:50","pubTimestamp":1789012238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司控股子公司上海脉示生物技术有限公司申报的医疗器械注册申请于近日获得了上海市药品监督管理局的受理，产品名称：四项抗癫痫药物浓度测定试剂盒(液相色谱串联质谱法)。该产品用于检测人体血清样本中的丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦浓度。临床上用于丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦血药浓度的监测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","IEIH","BK1583","PTH","BK0042","09996","MDEV","LNGR","BK1574","BK1100","AGNG","GDOC","300642","HART","MEDX","LGHT","BK0046","RSPH","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582190","title":"賽諾醫療：關於參加上海證券交易所科創板2026年半年度醫療器械及醫療設備行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582190","media":"同花顺","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582190?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:39","pubTimestamp":1788950340,"startTime":"0","endTime":"0","summary":"    证券日报网讯9月9日，赛诺医疗发布公告称，公司计划于2026年9月17日15：00-17：00参加上海证券交易所组织的科创板2026年半年度医疗器械及医疗设备行业集体业绩说明 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260909/c679749361.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260909/c679749361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["GDOC","09996","HART","LNGR","159883","MDEV","AGNG","KSTR","BK4585","MEDX","BK1574","PTH","RSPH","IEIH","BK1583","LGHT","BK4588","XHE","688108","BK0251","BK1100","IHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370679","title":"市場消息：派拉蒙天空之舞採取措施防範延期產生的成本，華納兄弟探索併購交易即將完成。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370679?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 05:12","pubTimestamp":1788901933,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PBPH","TBXU","RSPH","TMED","UYG","BK4108","BK4585","FFSM","IBBQ","CANC","PSP","AAUM","GTPE","WMG","IYH","XLFI","IEFN","RFG","BK4571","PRVT","ACTV","BK4588","MMID","DFMC","MNA","BK4561","PEVC","VXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666743903","title":"美國醫療保險和醫療補助服務中心：禁止11家涉嫌欺詐金額超過34億美元的醫療用品公司未來獲得聯邦醫療保險優勢計劃C部分和D","url":"https://stock-news.laohu8.com/highlight/detail?id=2666743903","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666743903?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 01:20","pubTimestamp":1788888000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0238689110.USD","LU0390134368.USD","LU0208291251.USD","LU0320765489.SGD","SG9999014005.SGD","LU1983260115.SGD","LU0256863811.USD","LU0266013472.USD","LU0211331839.USD","LU0170899867.USD","FXH","HUM","IHF","BK4588","UNHG","BK4154","UNHW","LU0070302665.USD","BK4566","LU0417517546.SGD","RSPH","SG9999014021.USD","LU0348723411.USD","IEHS","LU1093756168.USD","LU1093756325.SGD","BK4585","UNHU","SG9999014013.SGD","BK4533","UN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322648","title":"百事(PEP)拓展冷藏生鮮等新品類 應對GLP-1藥物帶來消費行為變化","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322648","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322648?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:52","pubTimestamp":1788864759,"startTime":"0","endTime":"0","summary":"据外媒报道，美国商超生鲜周边板块市场规模达2710亿美元，而百事过往在该领域布局较少，存在较大拓展空间。分析师表示，布局生鲜冷藏品类，有助于百事承接消费趋势，应对消费需求逐步从传统包装零食向外迁移的行业变化。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MWRmODAzMDJiNzRkNTY3ODIxNTExMzM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305808","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4534","BK4588","FTXG","RSPH","IE000BZT7R73.USD","LU0320765646.SGD","BK4550","THNR","IE00BN8TJ469.HKD","LU1244550577.SGD","IE00BBT3K403.USD","IE000F7OJYX1.SGD","LU1244550221.USD","LU1894683348.USD","LU1162221912.USD","LU1244550494.USD","LU0234572021.USD","LU1894683264.USD","MEDI","NVOH","BK4177","NVOX","JDOC","LU0098860793.USD","IE00BLSP4239.USD","IE00B3T34201.USD","LU1929549753.HKD","IE00BLSP4452.SGD","BK4566","IE000MB6IJN5.SGD","BK4504","IE000SO60NU8.SGD","IE0000B7K699.USD","IE000WAW04H5.SGD","BK4581","PEP","BK4533","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332349","title":"邁普醫學：可吸收止血流體明膠作為第三類醫療器械進入臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332349","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665332349?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:14","pubTimestamp":1788855283,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LGHT","RSPH","MEDX","IBBJ","LNGR","PSYK","AGNG","MDEV","IBBQ","IEIH","HART","BMED","MDTX","GDOC","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665434161","title":"中信建投：醫療器械業績持續改善 醫療服務收入平穩增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2665434161","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665434161?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 10:56","pubTimestamp":1788836160,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中信建投发布研报称，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。IVD：26Q2 IVD板块收入在过去两年来首次恢复正增长，利润端大幅增长。从收入端来看，二季度板块收入仍保持正增长，其中眼科医疗服务公司2025Q2低基数相对较低，但板块今年二季度收入增速相较一季度的增速有所降低，表明消费环境压力仍然存在。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MEDX","MDEV","AGNG","BK1100","601066","IEIH","HART","159883","GDOC","LNGR","09996","PTH","LGHT","BK1583","BK0276","BK1574","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311633","title":"諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311633","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311633?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:15","pubTimestamp":1788783311,"startTime":"0","endTime":"0","summary":"诺和诺德在声明中指出，这项名为STEP Young的试验所纳入的全部受试者，在整个研究期间均接受了生活方式干预，包括限制热量摄入和增加体育锻炼。诺和诺德首席科学官马丁·霍尔斯特·兰格表示：“STEP Young试验的积极结果令人振奋，我们看好司美格鲁肽在帮助罹患肥胖的儿童方面的潜力——这些儿童除生活方式调整外，尚需药物治疗以更有效地管理其肥胖状况。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["TRUH","NVOH","FHLC","RSPH","MEDI","BGIA","PINK","PJP","THNR","NBDS","NVOC","IYH","NVOX","CURE","FXH","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311616","title":"諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311616","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311616?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:15","pubTimestamp":1788783311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TRUH","FHLC","PJP","FXH","MEDI","PINK","NVOX","THNR","XLVI","BGIA","NBDS","RSPH","NVOH","CURE","NVOC","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665231964","title":"三諾生物：取得醫療器械註冊證及註冊變更文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2665231964","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665231964?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:24","pubTimestamp":1788780275,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","MEDX","RSPH","LNGR","PTH","HART","MDEV","AGNG","LGHT","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315638","title":"安圖生物：公司及子公司獲得四項醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315638","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315638?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:03","pubTimestamp":1788775426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","MEDX","RSPH","MDEV","GDOC","HART","LGHT","AGNG","IEIH","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665945893","title":"麥科田（2041.HK）登陸港交所，平台型醫療器械龍頭起航","url":"https://stock-news.laohu8.com/highlight/detail?id=2665945893","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665945893?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:10","pubTimestamp":1788761405,"startTime":"0","endTime":"0","summary":"麦科田通过多赛道布局、全球化运营、持续并购整合，构建一个抗周期、可持续的医疗器械平台。","market":"fut","thumbnail":"https://img2.gelonghui.com/52490-957b9937-e172-429c-8c01-0917b7b8c624.jpg?guru_height=2666&guru_width=4000&guru_size=1163899","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/52490-957b9937-e172-429c-8c01-0917b7b8c624.jpg?guru_height=2666&guru_width=4000&guru_size=1163899"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6537932","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1574","HEXmain","IEIH","MEDX","RSPH","LNGR","PTH","HART","02041","09996","159883","LGHT","MDEV","BK1100","AGNG","BK1583","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399937","title":"山東省寧陽縣市場監管局開展醫療器械專項現場檢查","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399937","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399937?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:37","pubTimestamp":1788755820,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 9月7日，山东省宁阳县市场监管局执法人员深入辖区零售药店，开展医疗器械专项现场检查。执法人员重点查看血压计等二类医疗器械，仔细核对产品注册资料、进货票据，查验产品有效期、包装标识，排查有无过期失效、来路不明产品等风险隐患。检查过程坚持监管和指导同步开展，现场向药店从业人员讲解医疗器械经营相关规定，指出经营中的不足，督促经营者落实主体责任，规范进货查验和日常自查工作。下一步，该局将持续加大医疗器械监管频次，紧盯零售药店经营风险，切实保障群众用械安全。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-07/doc-iniqykzy9680694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","BK1100","09996","159883","MDEV","PTH","IEIH","HART","BK1574","GDOC","RSPH","LGHT","BK1583","MEDX","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399350","title":"又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399350","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399350?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:07","pubTimestamp":1788754034,"startTime":"0","endTime":"0","summary":"随着多家医疗器械企业中报密集披露，医疗器械板块整体修复态势明确，业绩端已出现向上拐点。9月7日，麦科田正式于港交所挂牌上市，这意味着港股医疗器械板块再添一家平台型龙头。据多家权威机构测算，2026年全球医疗器械市场规模预计在6000亿至8000亿美元之间，并有望于2035年突破万亿美元大关。整体来看，麦科田此次登陆港股，业绩方面盈利拐点已经确认，商业化路径成熟，平台型的全面产品组合和全","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","RSPH","BK4585","LNGR","KCAI","IEIH","02041","BK4588","BK1100","159883","09996","BK1574","HART","MEDX","GDOC","VXUS","PTH","LGHT","AGNG","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665968913","title":"高瓴重倉的醫療器械公司，IPO首日開盤跌超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665968913","media":"直通IPO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665968913?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:01","pubTimestamp":1788750084,"startTime":"0","endTime":"0","summary":"然而，这家被高瓴资本重仓押注的企业，并未迎来开门红。上市首日，麦科田开盘即破发，股价报10港元/股，较发行价15.43港元大跌35.15%，总市值定格在53.86亿。值得注意的是，此次IPO未引入基石投资者。截至2026年3月31日，公司拥有320余款商业化医疗器械产品及60余款在研产品，覆盖全球逾140个国家及地区，经销商网络由2000余家经销商组成。尽管拥有强大的产业背景、稳健的基本面和明星机构背书，麦科田上市首日的股价表现依然不尽如人意。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/07110158370392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LGHT","BK1583","HART","BK1100","BK4127","LNGR","IEIH","KCE","REDS","MEDX","09996","FRHC","PTH","AGNG","159883","RSPH","IPOS","MDEV","GDOC","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665250366","title":"海南出台醫療器械委託生產監管新政","url":"https://stock-news.laohu8.com/highlight/detail?id=2665250366","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665250366?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 07:43","pubTimestamp":1788651815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","HART","LNGR","MDEV","PTH","GDOC","RSPH","LGHT","IEIH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665350040","title":"格式塔創始人彭雷：三到五年內，腦機接口本質上是嚴肅的醫療器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2665350040","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665350040?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 14:01","pubTimestamp":1788588060,"startTime":"0","endTime":"0","summary":"格式塔创始人、CEO彭雷表示，脑机接口赛道要解决的核心问题就一个：持续提高对脑内读写的分辨率。在他看来，至少在看得见的三到五年内，脑机接口本质上还是严肃的医疗器械，它的创新落地，付费方一定是医疗体系与患者。他指出，如何依托我国特色的医疗保障体系，让前沿的脑机接口应用纳入医保，惠及更多患者、解决实际病痛，这就是付费层面需要思考的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-09-05/doc-iniquccw0443893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1574","GDOC","09996","HART","IBRN","LNGR","RSPH","AGNG","IEIH","PTH","LGHT","159883","BK1583","MDEV","MNTL","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877326","title":"美國衞生與公眾服務部醫療保險和醫療補助服務中心：特朗普政府宣佈撥款1.2億美元，用於擴大印第安納州母嬰健康服務，提高初級","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877326","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:22","pubTimestamp":1788441723,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0320765489.SGD","LU0348723411.USD","BK4533","BK4588","RSPH","SG9999014013.SGD","LU1093756168.USD","LU1093756325.SGD","SG9999014021.USD","BK4581","BK4585","LU1983260115.SGD","LU0208291251.USD","IHF","LU0070302665.USD","LABU","LU0238689110.USD","HUM","LU0256863811.USD","XLV","SG9999014005.SGD","FXH","BK4154","LU0266013472.USD","XBI","BK4566","LU0211331839.USD","LU0390134368.USD","LU0417517546.SGD","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664987559","title":"浩歐博(688656.SH)子公司獲得13項醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664987559","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664987559?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 18:04","pubTimestamp":1788429879,"startTime":"0","endTime":"0","summary":"智通财经APP讯，浩欧博(688656.SH)发布公告，公司全资子公司湖南浩欧博生物医药有限公司于近日获得13项由湖南省药品监督管理局核准签发的医疗器械注册证。上述医疗器械注册证的取得，进一步丰富了公司化学发光平台检测菜单，有助于提升公司市场综合竞争力，对公司及子公司的可持续性发展将产生积极影响和促进作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LNGR","688656","159883","LGHT","MDEV","BK1574","09996","HART","GDOC","BK1583","BK1100","MEDX","IEIH","BK0239","RSPH","PTH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}